The angiotensin II receptor blocker candesartan improves survival and mesenteric perfusion in an acute porcine endotoxin model

Acta Anaesthesiologica Scandinavica

Volumn 48, Issue 2, 2004, Pages 198-204

  Laesser, M ^a   Oi, Y ^b   Ewert, S ^c   Fandriks L ^c   Åneman, Anders ^c  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b NIPPON MEDICAL SCHOOL   (Japan)

^c SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiotensin; Intestine; Receptors; Renin angiotensin system; Shock; Small; Swine

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BACTERIUM LIPOPOLYSACCHARIDE; CANDESARTAN; ESCHERICHIA COLI ENDOTOXIN;

ACID BASE BALANCE; ALKALOSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ARTIFICIAL VENTILATION; BOLUS INJECTION; CONTROLLED STUDY; ENDOTOXEMIA; ESCHERICHIA COLI; FEMALE; HEART OUTPUT; HEMODYNAMIC MONITORING; INTESTINE PERFUSION; JEJUNUM MUCOSA; KIDNEY CIRCULATION; KIDNEY PERFUSION; MALE; MESENTERY BLOOD FLOW; NONHUMAN; ORGAN PERFUSION; PRIORITY JOURNAL; RECEPTOR BLOCKING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SEPTIC SHOCK; SPLANCHNIC BLOOD FLOW; SURVIVAL; SWINE; VEIN BLOOD FLOW; VENOUS OXYGEN TENSION;

ACUTE DISEASE; ANIMALS; BENZIMIDAZOLES; CARDIAC OUTPUT; ENDOTOXEMIA; FEMALE; MALE; OXYGEN; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM; SPLANCHNIC CIRCULATION; SURVIVAL RATE; SWINE; TETRAZOLES;

EID: 0842348900     PISSN: 00015172     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.0001-5172.2004.00283.x     Document Type: Article

References (29)

1. Baxter F. Septic shock. Can J Anaesth 1997; 44: 59-72.
2. Vincent JL. Cardiovascular alterations in septic shock. J Antimicrob Chemother 1998; 41 (Suppl. A): 9-15.
3. Åneman A, Bengtsson J, Snygg J, Holm M, Pettersson A, Fändriks L. Differentiation of the peptidergic vasoregulatory response to standardized splanchnic hypoperfusion by acute hypovolaemia or sepsis in anaesthetized pigs. Acta Physiol Scand 1999; 166: 293-300.
4. Reilly PM, Wilkins KB, Fuh KC, Haglund U, Bulkley GB. The mesenteric hemodynamic response to circulatory shock: an overview. Shock 2001; 15: 329-43.
5. Marik PE, Varon J. The hemodynamic derangements in sepsis: implications for treatment strategies. Chest 1998; 114: 854-60.
6. Fettman MJ, Hand MS, Chandrasena LG, Cleek JL, Mason RA, Brooks PA et al. Effects of captopril on hemodynamic and metabolic parameters in awake endotoxinemic Yucatan minipigs. Circ Shock 1984; 12: 25-46.
7. Gennari R, Alexander JW, Boyce ST, Lilly N, Babcock GF, Gornaggia M. Effects of the angiotensin converting enzyme inhibitor enalapril on bacterial translocation after thermal injury and bacterial challenge. Shock 1996; 6: 95-100,
8. Vanhoutte PM. Endothelium and control of vascular function. State of the Art lecture. Hypertension 1989; 13: 658-67.
9. Akasu M, Urata H, Kinoshita A, Sasaguri M, Ideishi M, Arakawa K. Differences in tissue angiotensin II-forming pathways by species and organs in vitro. Hypertension 1998; 32: 514-20.
10. Urata H, Strobel F, Ganten D. Widespread tissue distribution of human chymase. J Hypertens 1994; 12 (Suppl. 9): S17-S22.
11. Altman DG. Practical statistics for medical research. London: Chapman & Hall, 1994.
12. Landow L, Andersen LW. Splanchnic ischaemia and its role in multiple organ failure. Acta Anaesthesiol Scand 1994; 38: 626-39.
13. Laesser M, Fandriks L, Pettersson A, Ewert S, Åneman A. Angiotensin II blockade in existing hypovolemia: effects of candesartan in the porcine splanchnic and renal circulation. Shock 2000; 14: 471-7.
14. Åneman A, Svensson M, Broome M, Biber B, Petterson A, Fändriks L. Specific angiotensin II receptor blockage improves intestinal perfusion during graded hypovolemia in pigs. Crit Care Med 2000; 28: 818-23.
15. von Engelhardt W. Swine cardiovascular physiology - a review. In: M R Bustad, LK, ed. Swine in Biomedical Research. Seattle. Frayn 1966, 307-329.
16. Schaller MD, Waeber B, Nussberger J, Brunner HR. Angiotensin II, vasopressin, and sympathetic activity in conscious rats with endotoxemia. Am J Physiol 1985; 249: H1086-H92.
17. Kilbourn RG, Gross SS, Jubran A, Adams J, Griffith OW, Levi R, Lodato RF. NG-methyl-L-arginine inhibits tumor necrosis factor-induced hypotension. implications for the involvement of nitric oxide. Proc Natl Acad Sci USA 1990; 87:3629-32.
18. Nyui N, Tamura K, Yamaguchi S, Nakamaru M, Ishigami T, Yabana M et al. Tissue angiotensinogen gene expression induced by lipopolysaccharide in hypertensive rats. Hypertension 1997; 30: 859-67.
19. Soden M, Klett C, Hasmann T, Hackenthal E. Angiotensinogen: an acute-phase protein? Hypertension 1994; 23: I126-I30.
20. Schmidt-Ott KM, Kagiyama S, Phillips MI. The multiple actions of angiotensin II in atherosclerosis. Regul Pept 2000; 93: 65-77.
21. Boldt J, Papsdorf M, Kumle B, Piper S, Hempelmann G. Influence of angiotensin-converting enzyme inhibitor enalaprilat on endothelial-derived substances in the critically ill. Crit Care Med 1998; 26: 1663-70.
22. Harding D, Baines PB, Brull D, Vassiliou V, Ellis I, Hart A et al. Severity of meningococcal disease in children and the angiotensin-converting enzyme insertion/deletion polymorphism. Am J Respir Crit Care Med 2002; 165: 1103-6.
23. Marshall RP, Webb S, Bellingan GJ, Montgomery HE, Chaudhari B, McAnulty RJ et al. Angiotensin converting enzyme insertion/deletion polymorphism is associated with susceptibility and outcome in acute respiratory distress syndrome. Am J Respir Crit Care Med 2002; 166: 646-50.
24. Tadros T, Traber DL, Heggers JP, Herndon DN. Angiotensin II inhibitor DuP753 attenuates burn- and endotoxin-induced gut ischemia, lipid peroxidation, mucosal permeability, and bacterial translocation. Ann Surg 2000; 231: 566-76.
25. Yunge M, Petros A. Angiotensin for septic shock unresponsive to noradrenaline. Arch Dis Child 2000; 82: 388-9.
26. Wray GM, Coakley JH. Severe septic shock unresponsive to noradrenaline. Lancet 1995; 346: 1604.
27. Ryding J, Heslet L, Hartvig T, Jonsson V. Reversal of 'refractory septic shock' by infusion of amrinone and angiotensin II in an anthracycline-treated patient. Chest 1995; 107: 201-3.
28. Oldner A, Wanecek M, Weitzberg E, Rundgren M, Alving K, Ullman J et al. Angiotensin II receptor antagonism increases gut oxygen delivery but fails to improve intestinal mucosal acidosis in porcine endotoxin shock. Shock 1999; 11: 127-35.
29. Vallet B, Lund N, Curtis SE, Kelly D, Cain SM. Gut and muscle tissue PO2 in endotoxemic dogs during shock and resuscitation. J Appl Physiol 1994; 76: 793-800.